Sasaki, Y., Miwa, K., Yamashita, K., Sunakawa, Y., Shimada, K., Ishida, H., . . . Katsumata, N. (2014). A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors. Invest New Drugs.
Citação norma ChicagoSasaki, Yasutsuna, et al. "A Phase I Study of Farletuzumab, a Humanized Anti-folate Receptor α Monoclonal Antibody, in Patients With Solid Tumors." Invest New Drugs 2014.
Citação norma MLASasaki, Yasutsuna, et al. "A Phase I Study of Farletuzumab, a Humanized Anti-folate Receptor α Monoclonal Antibody, in Patients With Solid Tumors." Invest New Drugs 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.